Tyler-Stone Wealth Management’s AbbVie ABBV Stock Holding History

Tyler-Stone Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$957K	Buy	5,154 +309	+6%	+$57.4K	0.15%	119
2025 Q1	$1.02M	Buy	4,845 +279	+6%	+$54.2K	0.18%	108
2024 Q4	$811K	Buy	4,566 +97	+2%	+$17.8K	0.14%	129
2024 Q3	$883K	Buy	4,469 +2,542	+132%	+$474K	0.17%	121
2024 Q2	$331K	Sell	1,927 -150	-7%	-$24.8K	0.14%	132
2024 Q1	$378K	Buy	2,077 +60	+3%	+$10.3K	0.17%	120
2023 Q4	$313K	Sell	2,017 -199	-9%	-$29K	0.16%	127
2023 Q3	$330K	Buy	2,216 +320	+17%	+$47K	0.19%	107
2023 Q2	$255K	Buy	+1,896	New	+$278K	0.14%	133
2022 Q4	$171K	Sell	1,056 -1,274	-55%	-$195K	0.12%	158
2022 Q3	$313K	Hold	2,330	–	–	0.24%	93
2022 Q2	$357K	Buy	2,330 +10	+0.4%	+$1.53K	0.24%	91
2022 Q1	$376K	Buy	2,320 +60	+3%	+$8.72K	0.21%	103
2021 Q4	$306K	Buy	+2,260	New	+$267K	0.16%	126

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Tyler-Stone Wealth Management's ABBV Position: Q2 2025 in Review

Tyler-Stone Wealth Management increased its AbbVie (ABBV) stake by 6.4% in Q2 2025, buying an estimated $57.4K and bringing the position to 5,154 shares worth $957K. The position accounts for 0.15% of the portfolio, ranked #119.

Tyler-Stone Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.02M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Tyler-Stone Wealth Management held 5,154 shares of AbbVie worth $957K as of Q2 2025.
Tyler-Stone Wealth Management bought 309 AbbVie shares in Q2 2025, an estimated $57.4K.
AbbVie made up 0.15% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #119 holding.
Tyler-Stone Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 14 quarters since.
Tyler-Stone Wealth Management's AbbVie position peaked at $1.02M in Q1 2025.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.